Cargando…

Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes

BACKGROUND: Diabetes mellitus is characterized by chronic vascular inflammation leading to pathological expression of the thrombogenic full length (fl) tissue factor (TF) and its isoform alternatively-spliced (as) TF. Blood-borne TF promotes factor (F) Xa generation resulting in a pro-thrombotic sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Witkowski, Marco, Witkowski, Mario, Saffarzadeh, Mona, Friebel, Julian, Tabaraie, Termeh, Ta Bao, Loc, Chakraborty, Aritra, Dörner, Andrea, Stratmann, Bernd, Tschoepe, Diethelm, Winter, Samantha J., Krueger, Andreas, Ruf, Wolfram, Landmesser, Ulf, Rauch, Ursula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027062/ https://www.ncbi.nlm.nih.gov/pubmed/32066445 http://dx.doi.org/10.1186/s12933-020-0993-z

Ejemplares similares

Micro–RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor
por: Witkowski, Marco, et al.
Publicado: (2016)

MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes
por: Witkowski, Marco, et al.
Publicado: (2018)

Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes
por: Witkowski, Marco, et al.
Publicado: (2020)

Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19
por: Puccini, Marianna, et al.
Publicado: (2023)

Heart in Diabetes: Not Only a Macrovascular Disease
por: Stratmann, Bernd, et al.
Publicado: (2011)

Shifting the Disease Management Paradigm From Glucose: What are the pros?
por: Stirban, Alin, et al.
Publicado: (2009)

Peripheral oscillometric arterial performance does not depict coronary status in patients with type 2 diabetes mellitus
por: Jaeger, Magdalene, et al.
Publicado: (2021)

Adenine Nucleotide Translocase 1 Expression Modulates the Immune Response in Ischemic Hearts
por: Yergöz, Fatih, et al.
Publicado: (2021)

Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial Fibrillation
por: Blöbaum, Leon, et al.
Publicado: (2023)

Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation
por: Friebel, Julian, et al.
Publicado: (2021)

Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel
por: Puccini, Marianna, et al.
Publicado: (2022)

Adenine Nucleotide Translocase 1 Expression Is Coupled to the HSP27-Mediated TLR4 Signaling in Cardiomyocytes
por: Winter, Julia, et al.
Publicado: (2019)

Impact of GLO1 Knock Down on GLUT4 Trafficking and Glucose Uptake in L6 Myoblasts
por: Engelbrecht, Britta, et al.
Publicado: (2013)

Cytotoxic CD8(+) T Cells Are Involved in the Thrombo-Inflammatory Response during First-Diagnosed Atrial Fibrillation
por: Friebel, Julian, et al.
Publicado: (2022)

Liraglutide and DPP-4 inhibitors – side effects comparative clinical study
por: TIMOFTE, LUMINIŢA, et al.
Publicado: (2013)

Intracellular Accumulation of Methylglyoxal by Glyoxalase 1 Knock Down Alters Collagen Homoeostasis in L6 Myoblasts
por: Stratmann, Bernd, et al.
Publicado: (2017)

Efficient Immunization of BALB/c Mice against Pathogenic Brucella melitensis and B. ovis: Comparing Cell-Mediated and Protective Immune Responses Elicited by pCDNA3.1 and pVAX1 DNA Vaccines Coding for Omp31 of Brucella melitensis
por: Harzandi, Naser, et al.
Publicado: (2021)

Chronic Hyperglycaemia Inhibits Tricarboxylic Acid Cycle in Rat Cardiomyoblasts Overexpressing Glucose Transporter Type 4
por: Stratmann, Bernd, et al.
Publicado: (2022)

Gliflozine – in Zukunft Kardioprotektiva?
por: Rauch-Kröhnert, Ursula, et al.
Publicado: (2021)

Mosaic vs. Single Image Analysis with Confocal Microscopy of the Corneal Nerve Plexus for Diagnosis of Early Diabetic Peripheral Neuropathy
por: Matuszewska-Iwanicka, Aleksandra, et al.
Publicado: (2022)

Device Thrombogenicity Emulation: An In Silico Predictor of In Vitro and In Vivo Ventricular Assist Device Thrombogenicity
por: Chiu, Wei Che, et al.
Publicado: (2019)

Pleiotropic Effects of PCSK9: Focus on Thrombosis and Haemostasis
por: Puccini, Marianna, et al.
Publicado: (2022)

Heparanase expression upregulates platelet adhesion activity and thrombogenicity
por: Cui, Hao, et al.
Publicado: (2016)

The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies
por: Ghanbari, Emily Parissa, et al.
Publicado: (2023)

Nanomedicine for the reduction of the thrombogenicity of stent coatings
por: Karagkiozaki, Varvara C, et al.
Publicado: (2010)

Extracellular Vesicles and Thrombogenicity in Atrial Fibrillation
por: Berezin, Alexander E., et al.
Publicado: (2022)

Tumor Genetics Are Thrombogenic: The Need for Action
por: Mahé, Isabelle, et al.
Publicado: (2023)

Tomographic Findings and Thrombogenic Effects of COVID-19
por: Mourão, Rodrigo, et al.
Publicado: (2020)

Targeting thrombogenicity and inflammation in chronic HIV infection
por: O’Brien, Meagan P., et al.
Publicado: (2019)

Thrombogenic and Inflammatory Reactions to Biomaterials in Medical Devices
por: Labarrere, Carlos A., et al.
Publicado: (2020)

Acute Macrovascular Dysfunction in Patients With Type 2 Diabetes Induced by Ingestion of Advanced Glycated β-Lactoglobulins
por: Stirban, Alin, et al.
Publicado: (2013)

Metabolomic Signature of Coronary Artery Disease in Type 2 Diabetes Mellitus
por: Stratmann, Bernd, et al.
Publicado: (2017)

Long non-coding RNA crnde promotes deep vein thrombosis by sequestering miR-181a-5p away from thrombogenic Pcyox1l
por: He, Xin, et al.
Publicado: (2023)

Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation
por: Jakobs, Kai, et al.
Publicado: (2022)

Thrombogenic Catheter-Associated Superior Vena Cava Syndrome
por: Shaikh, Imran, et al.
Publicado: (2013)

Response to “Tomographic Findings and Thrombogenic Effects of COVID-19”
por: Bao, Cuiping, et al.
Publicado: (2020)

Cryopreservation moderates the thrombogenicity of arterial allografts during storage
por: Hidi, László, et al.
Publicado: (2021)

Assessment of the Anti-Thrombogenic Activity of Polyurethane Starch Composites
por: Cespedes, Jhoan F., et al.
Publicado: (2022)

Effect of Cold Atmospheric Plasma Therapy vs Standard Therapy Placebo on Wound Healing in Patients With Diabetic Foot Ulcers: A Randomized Clinical Trial
por: Stratmann, Bernd, et al.
Publicado: (2020)

Diminished Thrombogenic Responses by Deletion of the Podocalyxin Gene in Mouse Megakaryocytes
por: Pericacho, Miguel, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_08h05pirdl6bv9298n5tfdv100